CD34+ Cell Dose Requirements for Rapid Engraftment in a Sequential High-Dose Chemotherapy Regimen of Paclitaxel, Melphalan, and Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) with PBPC Support in Metastatic Breast Cancer (Q60613628)
Jump to navigation
Jump to search
scientific article published on 01 August 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CD34+ Cell Dose Requirements for Rapid Engraftment in a Sequential High-Dose Chemotherapy Regimen of Paclitaxel, Melphalan, and Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) with PBPC Support in Metastatic Breast Cancer |
scientific article published on 01 August 1999 |
Statements
CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer (English)
Papadopoulos KP
Ayello J
Reiss RF
Kaufman E